TITLE:
Fluconazole Prophylaxis in Neonates (Non-Systematic) Literature Review
AUTHORS:
Abdulaziz Almulhim
KEYWORDS:
Invasive Candidiasis, Neonates, Preterm, Fluconazole Prophylaxis, Central Venous Catheters
JOURNAL NAME:
Pharmacology & Pharmacy,
Vol.7 No.12,
December
8,
2016
ABSTRACT: Background: Nosocomial infection remains an important contributing factor for morbidity and mortality in neonates. Coagulase-negative staphylococci have emerged as the predominant pathogens of late onset sepsis. This is followed by staphylococcus aurous, gram negative bacilli, and fungi. Old studies noted that mortality due to candidemia was higher in infants weigh less than 2000 g after being exposed to risk factors. The prophylactic use of fluconazole for the prevention of IC in extremely low birth weight was first reported in 2001. Methods: Current guidelines from Europe and North America that refer to the treatment of fungal infections are included. Literature search was performed using Medline, Scopus and Cochrane Central Register of Controlled Trials through March, 2016. Conclusion: Mortality was not different in early studies. However, recent studies concluded that mortality was reduced in the fluconazole arms. Risk-based approach towards fluconazole prophylaxis seems to be safe and effective.